SCHADREY BONDS: Open Payments
NPI 1023475282 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 18 payments from 11 companies in 2025. Trend: 2023 $474 · 2024 $622 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $278 |
| Exact Sciences Corporation | 4 | $158 |
| ARGENX US, INC. | 1 | $128 |
| Novo Nordisk Inc | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $117 |
| PFIZER INC. | 1 | $89 |
| Medtronic, Inc. | 1 | $73 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: VYVGART, BREZTRI, Wegovy, FARXIGA, The Cologuard Plus Collection Kit, JARDIANCE, PREVNAR 20, MAZOR X SYSTEM.
Industry payments across NV — which companies pay providers there.
